
    
      Twenty outpatients with Chronic Obstructive Lung Disease (COPD) and secondary pulmonary
      hypertension are treated in a cross-over design with Tadalafil or placebo for 4 weeks.
      Primary effect parameter is 6 min. walking test.
    
  